| pubmed-article:15381240 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15381240 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:15381240 | lifeskim:mentions | umls-concept:C0221198 | lld:lifeskim |
| pubmed-article:15381240 | lifeskim:mentions | umls-concept:C0333051 | lld:lifeskim |
| pubmed-article:15381240 | lifeskim:mentions | umls-concept:C1527144 | lld:lifeskim |
| pubmed-article:15381240 | lifeskim:mentions | umls-concept:C0918027 | lld:lifeskim |
| pubmed-article:15381240 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:15381240 | pubmed:dateCreated | 2004-9-21 | lld:pubmed |
| pubmed-article:15381240 | pubmed:abstractText | The inducement of Th1 cell-mediated immune response, possibly brought about through bacterial stimulation, may serve to control atopic disorders such as atopic dermatitis (AD). The streptococcal preparation, OK-432, has been shown a potent Th1 inducer through the action of IL-12. NC/Nga mice under ordinary conditions have been found to contract dermatitis similar to human AD. | lld:pubmed |
| pubmed-article:15381240 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15381240 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15381240 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15381240 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:15381240 | pubmed:issn | 0923-1811 | lld:pubmed |
| pubmed-article:15381240 | pubmed:author | pubmed-author:NishiokaKiyos... | lld:pubmed |
| pubmed-article:15381240 | pubmed:author | pubmed-author:HoriuchiYasuh... | lld:pubmed |
| pubmed-article:15381240 | pubmed:author | pubmed-author:KatayamaIchir... | lld:pubmed |
| pubmed-article:15381240 | pubmed:author | pubmed-author:BaeSangJaeS | lld:pubmed |
| pubmed-article:15381240 | pubmed:copyrightInfo | Copyright 2004 Japanese Society for Investigative Dermatology | lld:pubmed |
| pubmed-article:15381240 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15381240 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:15381240 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15381240 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15381240 | pubmed:pagination | 187-97 | lld:pubmed |
| pubmed-article:15381240 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:meshHeading | pubmed-meshheading:15381240... | lld:pubmed |
| pubmed-article:15381240 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15381240 | pubmed:articleTitle | Therapeutic effects of streptococcal preparation OK-432 on atopic dermatitis-like lesions in NC/Nga mice: possible shift from a Th2- to Th1-predominance. | lld:pubmed |
| pubmed-article:15381240 | pubmed:affiliation | Department of Dermatology, Nagaski University School of Medicine, 1-7-1 Sakamoto, Nagasaki, Japan. nu-yhori@jcom.home.ne.jp | lld:pubmed |
| pubmed-article:15381240 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15381240 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
